Plasma exchanges as treatment of severe acute immune thrombocytopenic purpura

被引:5
作者
Masseau, A
Guitton, C
Bretonnière, C
Renard, B
Villers, D
Hamidou, M
机构
[1] CHU Hotel Dieu, Serv Med Interne Pr Planchon, F-44093 Nantes, France
[2] CHU Hotel Dieu, Serv Reanimat Med Pr Villers, F-44093 Nantes, France
来源
REVUE DE MEDECINE INTERNE | 2005年 / 26卷 / 10期
关键词
immune thrombocytopenic purpura; lupus; plasma exchange;
D O I
10.1016/j.revmed.2005.06.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - High dose steroids and intravenous immunoglobulins are the gold treatment of acute immune thrombocytopenic purpura, before splenectomy for severe and refractory forms of the disease. Authors report two cases of severe acute refractory immune thombocytopenia with a dramatic response to plasma exchanges. Exegesis. - The first case was an idiopathic form, complicated by hemorragic peritoneal effusion. After failure of steroids, intravenous immunoglobulins and splenectomy and 2 courses of rituximab, plasmapheresis normalized in 3 days platelet count. In the second observation, ITP was associated to systemic lupus with antiphospholipids antibodies and multivisceral failure, despite steroids and intravenous immunoglobulins. After 3 plasma exchanges, platelet count was normalized, and the patient is under remission after 24 months follow-up. Conclusion. - Plasmapheresis must be evaluated as an emergency treatment in refractory forms of acute immune thrombocytopenic purpura. (c) 2005 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:824 / 826
页数:3
相关论文
共 14 条
  • [1] INTENSIVE PLASMA-EXCHANGE THERAPY IN 10 PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
    BLANCHETTE, VS
    HOGAN, VA
    MCCOMBIE, NE
    DROUIN, J
    BORMANIS, JD
    TAYLOR, R
    ROCK, GA
    [J]. TRANSFUSION, 1984, 24 (05) : 388 - 394
  • [2] BRANDA RF, 1978, LANCET, V1, P688
  • [3] Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura
    Brændstrup, P
    Bjerrum, OW
    Nielsen, OJ
    Jensen, BA
    Clausen, NT
    Hansen, PB
    Andersen, I
    Schmidt, K
    Andersen, TM
    Peterslund, NA
    Birgens, HS
    Plesner, T
    Pedersen, BB
    Hasselbalch, HC
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (04) : 275 - 280
  • [4] The Canadian experience using plasma exchange for immune thrombocytopenic purpura
    Buskard, N
    Rock, G
    Nair, R
    [J]. TRANSFUSION SCIENCE, 1998, 19 (03): : 295 - 300
  • [5] Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
    Cheng, YF
    Wong, RSM
    Soo, YOY
    Chui, CH
    Lau, FY
    Chan, NPH
    Wong, WS
    Cheng, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) : 831 - 836
  • [6] Medical progress: Immune thrombocytopenic purpura.
    Cines, DB
    Blanchette, VS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) : 995 - 1008
  • [7] ONE-YEAR FOLLOW-UP OF PLASMA-EXCHANGE THERAPY IN 14 PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
    MARDER, VJ
    NUSBACHER, J
    ANDERSON, FW
    [J]. TRANSFUSION, 1981, 21 (03) : 291 - 298
  • [8] Mead Adam J, 2003, Hematology, V8, P345, DOI 10.1080/1024533032000158850
  • [9] PLASMAPHERESIS IN CATASTROPHIC COMPLICATIONS OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
    NOVAK, R
    WILIMAS, J
    [J]. JOURNAL OF PEDIATRICS, 1978, 92 (03) : 434 - 436
  • [10] PETTERSSON T, 1987, EUR J HAEMATOL, V39, P92